Sonendo, Inc. announced changes to its leadership team. Andrew Kirkpatrick, chief operating officer, is stepping down from the position of Chief Operating Officer, effective June 1, 2023, to pursue new opportunities. The Company has also created two new roles to continue its focus on operational improvement and innovation. Effective May 1, 2023 John McGaugh will be joining the Company as vice president of Operations and earlier this year the Company promoted Kevin Yein to vice president, Research & Development. To continue focus on developing a scalable operations organization and improving gross margin profile, Sonendo has hired John McGaugh as vice president, Operations. Mr. McGaugh brings more than 20 years of global manufacturing and supply chain operations experience and leadership to Sonendo. He previously held leadership positions at companies such as Abbott Vascular, Boston Scientific, and American Medical Systems, developing expertise navigating the challenges of scalability and high growth manufacturing. Most recently at Abbott Vascular, he led a team of over 1500 employees and executed strategic initiatives to improve productivity, deliver significant cost savings, and optimize manufacturing networks, resulting in improved margins and cost reductions. Sonendo also promoted Kevin Yein to vice president R&D earlier this year. Mr. Yein joined Sonendo in early 2020 and since then has helped to grow and develop the R&D organization and processes while driving some of the Company's most important product development initiatives, including the innovative CleanFlow technology and GentleWave G4 System, both introduced in 2022. Prior to Sonendo, Mr. Yein led engineering and product development processes and programs for over a decade at Beckman Coulter, a Danaher Corporation, and also at L3Harris, a defense contractor.
Both Mr. McGaugh and Mr. Yein will report to Bjarne Bergheim and serve as members of the Company's management team.
Sonendo, Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. The Company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Company also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.
SONENDO, INC. 
